Health News Archive - May 19, 2010
LAKE FOREST, Ill., May 19 /PRNewswire-FirstCall/ -- Hospira, Inc.
The probiotic yogurt-like drink DanActive reduced the rate of common sicknesses such as ear infections, sinusitis, the flu and diarrhea in daycare children, say researchers who studied the drink in the largest known probiotic clinical trial to be conducted in the United States.
SOUTH SAN FRANCISCO, Calif., May 19 /PRNewswire/ -- A meta-analysis of approximately 80,000 individuals from 32 prospective studies was published in The Lancet on May 1, 2010.
Many Compliance and Ethics Officers Do Not Report to Board or CEO MINNEAPOLIS, May 19 /PRNewswire-USNewswire/ -- Compliance and ethics remain farther down the pecking order at publicly traded companies than it is at either privately held or non-profit organizations.
FOUNTAIN HILLS, Ariz., May 19 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that earlier this month, results were presented on a six-month independent study on PNT's effectiveness on ocular hypertension patients. The presentation given at ARVO (Association for Research in Vision and Ophthalmology) showed, as in other studies preformed, that PNT is a safe and effective treatment for glaucoma and ocular hypertension.
SAN FRANCISCO, May 19 /PRNewswire/ -- Five presentations reporting the results of two placebo-controlled clinical trials evaluating Ferring Pharmaceuticals' LYSTEDA(TM) (tranexamic acid) tablets, a novel, first-in-class, non-hormonal therapy indicated for treatment of women with cyclic heavy menstrual bleeding (HMB), were presented at The American College of Obstetricians and Gynecologists 58th Annual Clinical Meeting in San Francisco, May 15-19, 2010.
NEW YORK, May 19 /PRNewswire/ -- Momentum is building for the 16th Annual National Ergonomics Conference and Exposition (ErgoExpo), the largest and longest running ergonomics event in the nation, held at Caesars Palace, Las Vegas, November 30 - December 3, 2010.
MIAMI, May 19 /PRNewswire-FirstCall/ -- Physicians Healthcare Management Group, Inc.
Fibrin, the primary ingredient of blood clots, creates a fibrous network that stems the loss of blood at an injury site.
PHILADELPHIA, May 19 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, will present scientific data on its Attention Deficit Hyperactivity Disorder (ADHD) treatments VyvanseÂ® (lisdexamfetamine dimesylate) Capsules CII and INTUNIV(TM) (guanfacine) Extended Release Tablets at two national scientific meetings for psychiatrists May 20-26, 2010 in New Orleans, LA.
- A person in a secondary role, specifically the second most important character (after the protagonist).